admera_health_final_logo_transparent_final-100-3-300x122 Admera Health Homepage

Genetics for Smarter Medication Management

Admera Health provides
high-integrity end-to-end
pharmacogenomics solutions
PGxOnePlusPNG_logo_finalsmtm-1024x183 Admera Health Homepage

PGxOne™ Plus is a 60+ gene pharmacogenomics (PGx) test that can provide insight into how a patient will respond to certain drugs based on their DNA.

Built on the foundation of enabling the practice of smarter and safer healthcare, PGxOne™ Plus incorporates next-generation test design applications and expert data curation to deliver evidence-based medically actionable results.

8ae8ca5e-c998-453a-8ac9-27290eb1d81b Admera Health Homepage
PGxOnePlusPNG_logo_finalsmtm-300x53 Admera Health Homepage

PGxOne™ Plus is 62 a gene pharmacogenomics (PGx) test that can provide insight into how a patient will respond to certain drugs based on their DNA.

Built on the foundation of enabling the practice of smarter and safer healthcare, PGxOne™ Plus incorporates next-generation test design applications and expert data curation to deliver evidence-based medically actionable results.

8ae8ca5e-c998-453a-8ac9-27290eb1d81b Admera Health Homepage
Pharmacogenomics-1024x151 Admera Health Homepage

What is Pharmacogenomics?

Pharmacogenomics is the study of how genes affect a person’s response to drugs. This field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.
25aa0ab2-8d08-4d2c-a8d1-0d58d2930377 Admera Health Homepage
RxVisionPNG_logo_finalsmtm-300x72 Admera Health Homepage

Gain Additional Insight with RxVison™ 

In combination with RxVision™, Admera Health’s dynamic online reporting tool, the PGxOne™ Plus test delivers a complete PGx assessment for patient management solutions.
7ab1327b-3703-44de-b583-2c2a7af79bc6 Admera Health Homepage
How it Works

1

Sample_Type_Table_New-x2-e1598409425566 Admera Health Homepage

Provide a buccal swab,
mouth wash, blood,
or saliva sample

2

how_it_works_2 Admera Health Homepage

Ship the
specimen to
Admera Health

3

how_it_works_3 Admera Health Homepage

Admera Health
scientists sequence
and interpret DNA

4

how_it_works_4 Admera Health Homepage

Receive a
personalized
genetic report

Additional Precision Medicine Endeavors
From the lab bench to the clinic, Admera Health leverages existing knowledge and infrastructure to offer additional clinical services and robust Biopharma Services (BPS).

Clinical Services

a5775661-8e6b-48b9-b422-027acc0a720b Admera Health Homepage

AtheroGxOne™

Risk assessment for diseases that can cause early atherosclerosis.

CardioGxOne

Potential diagnosis of over 30 inherited cardiovascular diseases.

OncoGxOne

Comprehensive solid tumor profiling for targeted therapy selection.

Biopharma Services 

Admera Health’s Biopharma Services Department offers comprehensive genomics solutions for researchers worldwide.
2ff6a9cc-ecdc-4e79-b502-919079e46f33 Admera Health Homepage
CS_vert4.1Mobile-e1601314089149 Admera Health Homepage

Clinical Services

AtheroGxOne

Risk assessment for diseases that can cause early atherosclerosis.
Learn More >

CardioGxOne

Diagnose of over 30 inherited cardiovascular diseases.
Learn More >

OncoGxOne

Solid tumor profiling for targeted therapy selection.
Learn More >

Latest News

Admera Health CEO, Guanghui Hu, PhD, Awarded EY Entrepreneur Of The Year®

EY Announces Winners for the Entrepreneur Of The Year® 2020 New Jersey Award EY builds on three decades of honoring unstoppable entrepreneurs in New Jersey Ernst & Young LLP (EY US) is pleased to announce the winners of the Entrepreneur Of The Year® New Jersey Award. Entrepreneur Of The Year® is [...]

Admera Health Medical Director, Ruben Bonilla-Guerrero, MD, FACMG, FAACC, Awarded 2019 Outstanding Author

Admera Health Medical Director, Ruben Bonilla-Guerrero, MD, FACMG, FAACC, Awarded Annals of Translational Medicine Outstanding Author 2019 Dr. Ruben Bonilla-Guerrero was recently awarded 2019 Outstanding Author, in recognition of his great contribution entitled, "Laboratory diagnostic approaches in metabolic disorders" to Annals of Translational Medicine (Print ISSN 2305-5839; Online ISSN [...]

Load More Posts
Go to Top